drugset / Trial / NCT00264667
Study In Patients With Dyslipidaemia
RandomizedParallel-groupDouble-blindTreatment
Summary
Study in patients with dyslipidaemia.
Timeline
- Start
- 2005-12
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SODELGLITAZAR | Small molecule | 2.5 mg | Oral |
| Subject | SODELGLITAZAR | Small molecule | 5 mg | Oral |
| Subject | SODELGLITAZAR | Small molecule | 10 mg | Oral |
| Subject | SODELGLITAZAR | Small molecule | 20 mg | Oral |